» Authors » Alexandros Polymeris

Alexandros Polymeris

Explore the profile of Alexandros Polymeris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 376
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fandler-Hofler S, Eppinger S, Ambler G, Nash P, Kneihsl M, Lee K, et al.
JAMA Netw Open . 2024 Oct; 7(10):e2439571. PMID: 39405058
Importance: Cerebral small vessel disease (SVD) is associated with various cerebrovascular outcomes, but data on sex differences in SVD are scarce. Objective: To investigate whether the frequency, severity, and distribution...
2.
Siepen B, Polymeris A, Shoamanesh A, Connolly S, Steiner T, Poli S, et al.
Int J Stroke . 2024 Jan; 19(5):506-514. PMID: 38264861
Background: Data comparing the specific reversal agent andexanet alfa with non-specific treatments in patients with non-traumatic intracerebral hemorrhage (ICH) associated with factor-Xa inhibitor (FXaI) use are scarce. Aim: The study...
3.
Dittrich T, Aujesky M, Rudin S, Zietz A, Wagner B, Polymeris A, et al.
Eur Stroke J . 2023 May; 8(2):549-556. PMID: 37231698
Background: Computed tomography angiography (CTA) of the supraaortic arteries is commonly used for acute stroke workup and may reveal apical pulmonary lesions (APL). Aim: To determine the prevalence, follow-up algorithms,...
4.
Kimura S, Toyoda K, Yoshimura S, Minematsu K, Yasaka M, Paciaroni M, et al.
Stroke . 2022 Feb; 53(5):1540-1549. PMID: 35105180
Background: The "1-3-6-12-day rule" for starting direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation after acute ischemic stroke or transient ischemic attack recommends timings that may be later...
5.
Goldlin M, Radojewski P, Siepen B, Muller M, Wiest R, Mordasini P, et al.
Ther Umsch . 2021 Jul; 78(6):320-327. PMID: 34291658
Intracerebral haemorrhage - acute event and chronic disease Intracerebral hemorrhage accounts for 10-15% of all strokes and approximately 1'500-2'000 patients per year in Switzerland. Acute treatment by multi-disciplinary experts at...
6.
Best J, Ambler G, Wilson D, Lee K, Lim J, Shiozawa M, et al.
Lancet Neurol . 2021 Mar; 20(4):294-303. PMID: 33743239
Background: Balancing the risks of recurrent ischaemic stroke and intracranial haemorrhage is important for patients treated with antithrombotic therapy after ischaemic stroke or transient ischaemic attack. However, existing predictive models...
7.
Cappellari M, Seiffge D, Koga M, Paciaroni M, Forlivesi S, Turcato G, et al.
Eur Stroke J . 2021 Feb; 5(4):384-393. PMID: 33598557
Introduction: It is unknown whether the type of treatment (direct oral anticoagulant versus vitamin K antagonist) and the time of treatment introduction (early versus late) may affect the functional outcome...
8.
Dittrich T, Polymeris A, De Marchis G
Curr Opin Neurol . 2020 Nov; 34(1):38-44. PMID: 33230038
Purpose Of Review: Direct oral anticoagulants (DOAC) are crucial for the prevention of thromboembolic events in patients with nonvalvular atrial fibrillation. Drug adherence by the patient but also adherence to...
9.
Kronlage C, Hardmeier M, Bally S, Scholz M, Bucher H, Muller O, et al.
Lancet . 2020 Oct; 396(10256):990. PMID: 33010844
No abstract available.
10.
Altersberger V, Kellert L, Al Sultan A, Martinez-Majander N, Hametner C, Eskandari A, et al.
Eur Stroke J . 2020 Jul; 5(2):138-147. PMID: 32637647
Introduction: Alterations in haemoglobin levels are frequent in stroke patients. The prognostic meaning of anaemia and polyglobulia on outcomes in patients treated with intravenous thrombolysis is ambiguous. Patients And Methods:...